Business Standard

Medicamen Biotech consolidated net profit rises 31.06% in the September 2021 quarter

Image

Capital Market

Sales rise 5.69% to Rs 32.52 crore

Net profit of Medicamen Biotech rose 31.06% to Rs 4.22 crore in the quarter ended September 2021 as against Rs 3.22 crore during the previous quarter ended September 2020. Sales rose 5.69% to Rs 32.52 crore in the quarter ended September 2021 as against Rs 30.77 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales32.5230.77 6 OPM %19.1318.04 -PBDT6.405.30 21 PBT5.054.60 10 NP4.223.22 31

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 03 2021 | 5:06 PM IST

Explore News